696 studies found for:    lung tumor | Studies With Results
Show Display Options
Rank Status Study
1 Completed
Has Results
Phase II Study for Previously Untreated Subjects With Non Small Cell Lung Cancer (NSCLC) or Small Cell Lung Cancer (SCLC)
Conditions: Lung Cancer;   Small Cell Lung Cancer;   Carcinoma, Non-Small-Cell Lung
Interventions: Drug: Ipilimumab;   Drug: Placebo;   Drug: Paclitaxel;   Drug: Carboplatin
2 Completed
Has Results
Sputum Labeling Utilizing Synthetic Meso Tetra (4-Carboxyphenyl) Porphine (TCPP) for Detection of Lung Cancer
Condition: Lung Cancer
Intervention: Device: CyPath
3 Terminated
Has Results
Selenium in Preventing Tumor Growth in Patients With Previously Resected Stage I Non-small Cell Lung Cancer
Condition: Lung Cancer
Interventions: Other: placebo;   Drug: selenium
4 Terminated
Has Results
Phase I/II Calcitriol in Lung Cancer
Condition: Non Small Cell Lung Cancer
Intervention: Drug: Calcitriol
5 Completed
Has Results
National Lung Screening Trial (NLST) Screening
Condition: Lung Cancer
Interventions: Device: low-dose helical computed tomography;   Device: chest radiography
6 Active, not recruiting
Has Results
Screening for Lung Cancer in Older Patients (PLCO Screening Trial)
Condition: Lung Carcinoma
Interventions: Procedure: Radiography;   Other: Screening Questionnaire Administration
7 Terminated
Has Results
Dichloroacetate (DCA) in Patients With Previously Treated Metastatic Breast or Non-Small Cell Lung Cancer (NSCL)
Conditions: Metastatic Breast Cancer;   Lung Cancer
Intervention: Drug: Dichloroacetate (DCA)
8 Completed
Has Results
A Non-interventional Trial of Erlotinib (Tarceva) Metastatic Non-small Cell Lung Cancer
Condition: Non-Small Cell Lung Cancer
Intervention: Drug: Erlotinib
9 Terminated
Has Results
GW786034 in Patients With Non Small Cell Lung Cancer 3rd Line
Condition: Non Small Cell Lung Cancer
Intervention: Drug: Pazopanib (GW786034)
10 Completed
Has Results
A Study Of SU011248 As Therapy In Patients With Locally Advanced Or Metastatic Non-Small Cell Lung Cancer
Condition: Non-small Cell Lung Cancer
Interventions: Drug: carboplatin;   Drug: paclitaxel;   Drug: sunitinib
11 Completed
Has Results
Trial of RAD001 in Patients With Operable Non-Small Cell Lung Cancer (NSCLC)
Condition: Lung Cancer
Intervention: Drug: RAD001
12 Completed
Has Results
Topotecan and Bevacizumab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer That Did Not Respond to Previous Systemic Chemotherapy
Condition: Lung Cancer
Interventions: Biological: bevacizumab;   Drug: topotecan hydrochloride
13 Completed
Has Results
Residual Hypermethylation in Early Stage Non-Small Cell Lung Cancer (NSCLC) As Part of Adjuvant Therapy and Preventive Strategy
Conditions: Lung Cancer;   Non Small Cell Lung Carcinoma;   Hypermethylation
Interventions: Drug: Cisplatin;   Drug: Carboplatin;   Drug: Paclitaxel;   Drug: Vidaza;   Procedure: Tumor Specimen for Methylation Analysis;   Procedure: Blood Sample for Methylation Analysis;   Drug: Vinorelbine;   Drug: Docetaxel;   Drug: Pemetrexed
14 Terminated
Has Results
GRN1005 in Non-Small Cell Lung Cancer (NSCLC) Patients With Brain Metastases (GRABM-L)
Condition: Non-small Cell Lung Cancer (NSCLC) With Brain Metastases
Intervention: Drug: GRN1005
15 Terminated
Has Results
Zometa Adjuvant Treatment of Malignant Pleural Effusion Due To Non-Small Cell Lung Cancer
Conditions: Malignant Pleural Effusion;   Non Small Cell Lung Cancer
Intervention: Drug: zoledronic acid
16 Completed
Has Results
Carboxyamidotriazole in Treating Patients With Stage III or Stage IV Non-small Cell Lung Cancer
Conditions: Stage IIIA Non-small Cell Lung Cancer;   Stage IIIB Non-small Cell Lung Cancer;   Stage IV Non-small Cell Lung Cancer
Interventions: Drug: carboxyamidotriazole;   Other: placebo;   Procedure: quality-of-life assessment;   Other: laboratory biomarker analysis
17 Completed
Has Results
Allogeneic Cellular Vaccine 1650-G for Non-Small Cell Lung Cancer
Condition: Non-Small Cell Lung Cancer
Intervention: Drug: 1650-G Vaccine
18 Terminated
Has Results
Evaluation of Apricoxib (Selective Cyclooxygenase 2 Inhibition) in Modulating T Regulatory Cells of Patients With Early Stage Non-small Cell Lung Cancer
Condition: Non Small Cell Lung Cancer
Intervention: Drug: Apricoxib
19 Completed
Has Results
Irinotecan and Carboplatin as First-Line Therapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer
Condition: Lung Cancer
Interventions: Drug: Carboplatin;   Drug: irinotecan hydrochloride
20 Completed
Has Results
A Randomized Trial Of PF-00299804 Taken Orally Versus Erlotinib Taken Orally For Treatment Of Advanced Non-Small Cell Lung Cancer That Has Progressed After One Or Two Prior Chemotherapy Regimen
Condition: Non-small Cell Lung Cancer
Interventions: Drug: Erlotinib;   Drug: PF-00299804

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years